Agoraphobia
Fear of places and situations that might cause panic, helplessness, or embarrassment.
Agoraphobia is an anxiety disorder that often develops after one or more panic attacks.
Symptoms include fear and avoidance of places and situations that might cause feelings of panic, entrapment, helplessness, or embarrassment.
Treatments include talk therapy and medication.
Cluster Number: F-1
Wiki Number: W003
Diagnosis: Agoraphobia
US Patients: 1.7% Adults
World Patients:
Sex Ratio: M-2W
Age Onset: 20+
Brain Area: Extra epinephrine – poor balance
Symptoms: environment unsafe-no escape
Progression: Open spaces or outside home; may lead to 10-30 minute panic attack or PTSD
Causes:
Medications: antidepressants; anti-anxiety
Therapies: relaxation, systematic desensitization, expanding exposuresCBT-50%
Youtube Video: What is Agoraphobia?
Amazon or Library Book:
The Agoraphobia Workbook
Click on the book to link or buy from Amazon.
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.06.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Cell-type-specific hypothalamic pathways to brainstem drive context-dependent strategies in response to stressorsby Mehran Ahmadlou on May 16, 2024
Adaptive behavioral responses to stressors are critical for survival. However, which brain areas orchestrate switching the appropriate stress responses to distinct contexts is an open question. This study aimed to identify the cell-type-specific brain circuitry governing the selection of distinct behavioral strategies in response to stressors. Through novel mouse behavior paradigms, we observed distinct stressor-evoked behaviors in two psycho-spatially distinct contexts characterized by...
- Assessment of anxiety in children with neurodevelopment disorders: Rasch analysis of the Spence Children's Anxiety Scaleby Alana Sparks on May 14, 2024
Anxiety is common in neurodevelopmental disorders (NDD). The parent version of the Spence Children's Anxiety Scale (SCAS-P) is a widely used measure to assess anxiety across a broad range of childhood populations. However, assessment of the measurement properties of the SCAS-P in NDDs have been limited. The present study aimed to assess the psychometric properties of the SCAS-P in children with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) using Rasch...
- Cross-sectional study of psychiatric disorders in patients with chronic musculoskeletal pain and individuals without painby Ruben Horst Duque on May 10, 2024
CONCLUSION: Positive correlations of mental disorders and chronic musculoskeletal pain have been documented. This suggests that psychiatric components must be taken into account in the management of chronic pain syndromes. The use of Mini Plus as a diagnostic tool for psychiatric disorders can contribute to optimizing the diagnosis and treatment of patients with chronic pain and encourage the creation of policies with strategies and criteria for quick access to Multi-professional Services.
- Psoriasis and mental health in adolescents: A cross-sectional study within the Danish National Birth Cohortby Sandra L Brandi on May 4, 2024
CONCLUSION: Psoriasis is associated with poor mental health in adolescents. This appears to be driven by adolescents with psoriasis also reporting joint pain and is less evident in those with a doctor-confirmed diagnosis.